Get startedLog in
    Picture of SAB Biotherapeutics logo

    SABS — SAB Biotherapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapNeutral
    All News

    Brief: SAB Biotherapeutics Inc- Cash And Cash Equivalents Were $15.0 Million As Of December 31, 2022

    Picture of SAB Biotherapeutics logoSAB Biotherapeutics
    31/03/2023 22:34
    March 31 (Reuters) - SAB Biotherapeutics Inc  SABS.O :
    * SAB BIOTHERAPEUTICS INC- CASH AND CASH EQUIVALENTS WERE
$15.0
MILLION AS OF DECEMBER 31, 2022

Source text for Eikon:  ID:nGNXjZFFf 
Further company coverage:  SABS.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on SAB Biotherapeutics

    See all news